Evotec SE (EVO)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$1.70
+0.59%
Mkt Cap $1.08B
Analyst Ratings
No recent rating data.
Price Target (6 analysts)
$3.00
Range $2.00 – $4.00
Implied Upside
+76.5%
Consensus $3.00 vs current $1.70
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$1.70
+0.59%
Mkt Cap $1.08B
No recent rating data.
Price Target (6 analysts)
$3.00
Range $2.00 – $4.00
+76.5%
Consensus $3.00 vs current $1.70